Cargando…

Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report

Detalles Bibliográficos
Autores principales:	FAN, Birao, WANG, Mingyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558324/ https://www.ncbi.nlm.nih.gov/pubmed/35604239 http://dx.doi.org/10.2340/actadv.v102.1378

Ejemplares similares

The JAK1/2 inhibitor ruxolitinib delays premature aging phenotypes
por: Griveau, Audrey, et al.
Publicado: (2020)

Thalidomide as a potential adjuvant treatment for paraneoplastic pemphigus: A single‐center experience
por: Wang, Jingying, et al.
Publicado: (2020)

Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis
por: Keenan, Camille, et al.
Publicado: (2021)

Paraneoplastic Pemphigus Mimicking Toxic Epidermal Necrolysis Associated with Follicular Lymphoma: Possible Pathological Role of CD8 T Cells
por: KOKUBU, Hiraku, et al.
Publicado: (2020)

Atomic Simulation of the Binding of JAK1 and JAK2 with the Selective Inhibitor Ruxolitinib
por: Kondratyev, Maxim, et al.
Publicado: (2022)

Paraneoplastic pemphigus: A detailed case series from the Netherlands revealing atypical cases
por: Zaheri, Farhat, et al.
Publicado: (2022)

A Case Report on Paraneoplastic Pemphigus Associated Colonic Carcinoma
por: Wang, Yan-Zhao, et al.
Publicado: (2016)

Castleman's Disease with Paraneoplastic Pemphigus
por: Dinesha,, et al.
Publicado: (2014)

Paraneoplastic Pemphigus: Paraneoplastic Autoimmune Disease of the Skin and Mucosa
por: Kim, Jong Hoon, et al.
Publicado: (2019)

Paraneoplastic pemphigus: a short review
por: Wieczorek, Marta, et al.
Publicado: (2016)

Paraneoplastic Pemphigus Mimicking Pemphigus Vulgaris Associated With Castleman Disease
por: Grigore, Mariana, et al.
Publicado: (2023)

A case of Paraneoplastic Pemphigus associated with Castleman's disease
por: Zeng, Meihua, et al.
Publicado: (2013)

Paraneoplastic pemphigus associated with chronic lymphocytic leukemia: a case report
por: Konichi-Dias, Richard Lucas, et al.
Publicado: (2018)

Paraneoplastic pemphigus associated with chronic lymphocytic leukemia: A case report
por: Jiang, Qu, et al.
Publicado: (2017)

Paraneoplastic pemphigus associated with small lymphocytic lymphoma: A case report
por: Wang, Dafen, et al.
Publicado: (2021)

Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus
por: Porro, Adriana Maria, et al.
Publicado: (2014)

Paraneoplastic Pemphigus: A Paraneoplastic Autoimmune Multiorgan Syndrome or Autoimmune Multiorganopathy?
por: Mahajan, Vikram K., et al.
Publicado: (2012)

Deep pemphigus (pemphigus vulgaris, pemphigus vegetans and paraneoplastic pemphigus) in dogs, cats and horses: a comprehensive review
por: Tham, Heng L., et al.
Publicado: (2020)

Paraneoplastic pemphigus secondary to neuroendocrine carcinoma
por: Yee, Megan D., et al.
Publicado: (2021)

Paraneoplastic Pemphigus: An Indication for Treatment in Chronic Lymphocytic Leukemia
por: Onukogu, Ifeanyichukwu, et al.
Publicado: (2020)

Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis
por: Didona, Dario, et al.
Publicado: (2020)

Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation
por: Cattalini, Marco, et al.
Publicado: (2021)

Castleman disease and paraneoplastic pemphigus in a pregnant woman: A case report
por: Cui, Beibei, et al.
Publicado: (2021)

Paraneoplastic pemphigus and Castleman’s disease: a case report and a revision of the literature
por: Irrera, Mariangela, et al.
Publicado: (2023)

Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
por: FETTER, Tanja, et al.
Publicado: (2020)

The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases
por: TÜRK, Can, et al.
Publicado: (2019)

Retroperitoneal Castleman's tumor and paraneoplastic pemphigus: report of a case and review of the literature
por: Menenakos, Charalambos, et al.
Publicado: (2007)

A Case Report of Paraneoplastic Pemphigus Associated with Esophageal Squamous Cell Carcinoma
por: Cho, Jin Hyun, et al.
Publicado: (2013)

Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
por: Smith, Paul, et al.
Publicado: (2021)

Systemic lupus erythematosus combined with Castleman disease and secondary paraneoplastic pemphigus: a case report
por: Ma, Xin, et al.
Publicado: (2023)

Paraneoplastic pemphigus regression after thymoma resection
por: Barbetakis, Nikolaos, et al.
Publicado: (2008)

Paraneoplastic Pemphigus Involving the Respiratory and Gastrointestinal Mucosae
por: Odani, Kentaro, et al.
Publicado: (2020)

Renal cell carcinoma-induced paraneoplastic pemphigus
por: Gaurav, Vishal, et al.
Publicado: (2022)

Paraneoplastic pemphigus: initial manifestation of lung cancer
por: Webster, Guilherme, et al.
Publicado: (2015)

Design of Clinical Trials Evaluating Ruxolitinib, a JAK1/JAK2 Inhibitor, for Treatment of COVID-19–Associated Cytokine Storm
por: Langmuir, Peter, et al.
Publicado: (2020)

Paraneoplastic pemphigus: a clinical, laboratorial, and therapeutic overview
por: Maruta, Celina Wakisaka, et al.
Publicado: (2019)

Paraneoplastic Pemphigus: A Striking Complication of Undiagnosed Lymphoma
por: Adnani, Blake O., et al.
Publicado: (2022)

Coexistence of Discoid Lupus Erythematosus and Paraneoplastic Pemphigus: A Case Report and Literature Review
por: Saowaluksakul, Wasin, et al.
Publicado: (2022)

Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib
por: Mascarenhas, J, et al.
Publicado: (2012)

New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib
por: Marcuzzi, Annalisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8a7q9igblgoadl2v75bbe0jtrq